Bringing together science, technology, and comprehensive
solutions to redefine what's possible in healthcare
BRACKNELL, England,
June 10, 2021 /PRNewswire/ -- As the
world of healthcare and its dependence on auscultation continues to
evolve, digital technology is being introduced to meet the
advancing demands of the industry. To meet these changing needs,
3M™ Littmann® Stethoscopes and Eko formed a
collaboration that has married best-in-class 3M Littmann stethoscope technology with advanced
Eko digital innovations. The 3M™ Littmann® CORE Digital
Stethoscope, which has quickly become a popular choice among
physicians in the United States
over the last six months1, has launched in the
United Kingdom & Ireland.
The new 3M Littmann CORE Digital
Stethoscope offers clinicians access to both analogue and digital
auscultation options and can connect to Eko's software app via
Bluetooth. The Littmann CORE Stethoscope offers access to
additional benefits including:
- User can switch from analogue listening to digital
- Amplification2 up to 40x at peak frequency, versus
mechanical
- Seven sound amplification levels
- Provides active noise cancelation
- Connects to Eko software on a smart device to visualise,
record, store & share auscultation assessment
"3M Littmann Stethoscopes is a
pioneer in auscultation innovation and quality, and today, we are
introducing our most advanced stethoscope yet to Europe," said Kristi
Barnett, senior director, 3M
Medical Devices. "The new 3M Littmann
CORE Digital Stethoscope combines the superior acoustics of the
Littmann Cardiology IV Stethoscope with Eko's digital technology
and software to aid and enhance a clinician's auscultation
assessments."
The collaboration between 3M
Littmann Stethoscopes and Eko brings together two innovative
companies that are focused on delivering comprehensive health care
solutions to drive better patient outcomes.
"For clinicians, listening is a gateway to making critical
diagnoses. Being able to confidently assess heart and lung sounds
helps ensure the best cardiac and pulmonary care possible," said
Connor Landgraf, co-founder and CEO,
Eko. "Partnering with 3M Littmann
Stethoscopes allows us to incorporate the power of our digital and
machine learning technology alongside the stethoscope trusted by
millions of clinicians worldwide, which can help impact patient
outcomes and quality of care in Europe. Combining the 3M Littmann CORE Digital Stethoscope with the Eko
software platform helps clinicians elevate cardiopulmonary care to
a whole new level."
The combination allows a healthcare professional located outside
of secondary care, treating patients in their homes or in a
community practice, to have access to cutting-edge clinical
decision support. Also available is the ability to connect directly
to their consultant in secondary care, mitigating the need for the
patient to make unnecessary travel into traditional clinic
environments.
In the midst of a global pandemic, and the highly challenging
need to assess and monitor COVID patients, this can be leveraged as
a means to protect healthcare professionals, whilst providing the
highest standards of care.
The very same function that allows the streaming of the sounds
from the Littmann CORE Stethoscope via the Eko app, and to a
variety of wired and Bluetooth headphones, can also facilitate
communication to several hearing aid models, providing a
long-awaited solution for many hearing-impaired healthcare
professionals.
For more information on the 3M
Littmann CORE Stethoscope or where to buy, please visit:
www.littmann.co.uk/CORE. For more on Eko software, please visit
ekohealth.com/platform.
1Average product rating of 4.6 out of 5 stars on
Amazon in the United States as of
March 10, 2021.
2Up to 40x amplification based on comparison of analogue
versus electronically assisted amplified listening with maximum
volume at the peak frequency (125 Hz).
About 3M
At 3M, we apply science in collaborative ways to
improve lives daily as our employees connect with customers all
around the world. Learn more about 3M's creative solutions to
global challenges at www.3M.com or on
Twitter @3M or @3MNews.
About Eko
Eko, a cardiopulmonary digital health company, is elevating the
way clinicians detect and monitor cardiac and respiratory disease
by bringing together advanced sensors, patient and provider
software, and AI-powered analysis. Its FDA-cleared platform is used
by tens of thousands of clinicians treating millions of patients
around the world, in-person and through telehealth. The company is
headquartered in Oakland,
California, with investments from Highland Capital Partners,
Questa Capital, Artis Ventures, NTTVC, DigiTx Partners, Mayo
Clinic, Sutter Health, and others. For more information visit
www.ekohealth.com.
Logo - https://mma.prnewswire.com/media/1343410/3M_Logo.jpg